Needham Reiterates Hold on Moderna
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Joseph Stringer has reiterated a Hold rating on Moderna (NASDAQ:MRNA).
August 01, 2024 | 8:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Needham analyst Joseph Stringer has reiterated a Hold rating on Moderna. This suggests that the analyst does not see significant upside or downside potential in the short term.
The reiteration of a Hold rating by Needham suggests that the analyst believes Moderna's stock is fairly valued at its current price. This typically indicates that no significant price movement is expected in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100